Abstract
This review assesses the parallel data on the role of gamma-aminobutyric acid (GABA) in depression and anxiety. We review historical and new data from both animal and human experimentation which have helped define the key role for this transmitter in both these mental pathologies. By exploring the overtop in these conditions in terms of GABAergic neurochemistry, neurogenetics, brain circuitry, and pharmacology, we develop a theory that the two conditions are intrinsically interrelated. The role of GABAergic agents in demonstrating this interrelationship and in pointing the way to future research is discussed.
| Original language | English |
|---|---|
| Pages (from-to) | 495-517 |
| Number of pages | 23 |
| Journal | Depression and Anxiety |
| Volume | 24 |
| Issue number | 7 |
| DOIs | |
| Publication status | Published - 2007 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Anxiety
- Benzodiazepine receptors
- Common pathogenesis
- Depression
- GABA
Fingerprint
Dive into the research topics of 'Role of GABA in anxiety and depression'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver